Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression

(2020) Meghan Hibicke et al.   ACS Chemical Neuroscience

Emotions and brain function are altered up to one month after a single high dose of psilocybin

(2020) Frederick S. Barrett et al.   Scientific Reports

Psychedelic Psychiatry’s Brave New World

(2020) David Nutt et al.   CELL

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

(2020) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

A non-hallucinogenic psychedelic analogue with therapeutic potential

(2020) Lindsay P. Cameron et al.   NATURE

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

(2020) Alan K. Davis et al.   JAMA Psychiatry

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

(2019) Martin K. Madsen et al.   NEUROPSYCHOPHARMACOLOGY

Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat

(2019) Oskar Jefsen et al.   ACTA NEUROPSYCHIATRICA

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

(2019) Ronald S. Duman et al.   NEURON

Profiling of behavioral effects evoked by ketamine and the role of 5HT2 and D2 receptors in ketamine-induced locomotor sensitization in mice

(2019) Jefferson P. Galvanho et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

(2018) Jennifer W. Evans et al.   BIOLOGICAL PSYCHIATRY

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

(2018) Matthew W. Johnson et al.   NEUROPHARMACOLOGY

Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice

(2018) Amanda M. Dossat et al.   NEUROPHARMACOLOGY

Psychedelics Promote Structural and Functional Neural Plasticity

(2018) Calvin Ly et al.   Cell Reports

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

(2018) Leor Roseman et al.   Frontiers in Pharmacology

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

(2017) R. L. Carhart-Harris et al.   PSYCHOPHARMACOLOGY

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

(2017) Robin L Carhart-Harris et al.   Scientific Reports

Serotonin excites hippocampal CA1 GABAergic interneurons at the stratum radiatum-stratum lacunosum moleculare border

(2016) Daniel R. Wyskiel et al.   HIPPOCAMPUS

An excitatory synapse hypothesis of depression

(2015) Scott M. Thompson et al.   TRENDS IN NEUROSCIENCES

Chronic Stress Induces a Selective Decrease in AMPA Receptor-Mediated Synaptic Excitation at Hippocampal Temporoammonic-CA1 Synapses

(2013) A. J. Kallarackal et al.   JOURNAL OF NEUROSCIENCE

Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on   Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations

(2013) M. Kometer et al.   JOURNAL OF NEUROSCIENCE

Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression

(2013) Xiang Cai et al.   NATURE NEUROSCIENCE

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

(2012) Michael Kometer et al.   BIOLOGICAL PSYCHIATRY

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

(2011) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

(2010) Adam L Halberstadt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs

(2008) Pau Celada et al.   BIOLOGICAL PSYCHIATRY